We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Antiplatelet agents for chronic kidney disease.
- Abstract
The article offers information on the harms and benefits of antiplatelet agents such as dipyridamole, sulfinpyrazone, and glycoproteins to standard treatment of chronic kidney diseases patients. It states that the people with chronic kidney disease who had an acute coronary syndrome had no effect on myocardial infarction, but increased in major bleeding. It adds that antiplatelet agents are use in preventing cardiovascular events in the population.
- Subjects
PLATELET aggregation inhibitors; DIPYRIDAMOLE; SULFINPYRAZONE; GLYCOPROTEINS; KIDNEY disease treatments; ACUTE coronary syndrome; MYOCARDIAL infarction
- Publication
Nephrology, 2013, Vol 18, Issue 6, p474
- ISSN
1320-5358
- Publication type
Article
- DOI
10.1111/nep.12055